Treatment of dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor and erythropoietin

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 4, 2003, Pages 333-335

  Erduran, Erol ^a   Hacisalihoglu, Sadan ^a   Ozoran, Yavuz ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Dyskeratosis congenita; Erythropoietin; Granulocyte macrophage colony stimulating factor; Pancytopenia

Indexed keywords

DEFEROXAMINE; ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANEMIA; ARTICLE; BONE MARROW DEPRESSION; CASE REPORT; CLINICAL FEATURE; DYSKERATOSIS CONGENITA; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; HEPATOSPLENOMEGALY; HUMAN; LEUKOPENIA; MALE; PALLOR; PANCYTOPENIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT INFECTION; SKIN MANIFESTATION; TREATMENT OUTCOME;

BLOOD CELL COUNT; BONE MARROW; CHILD, PRESCHOOL; DEFEROXAMINE; DISEASE SUSCEPTIBILITY; DYSKERATOSIS CONGENITA; ERYTHROPOIETIN; FERRITINS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MALE; PANCYTOPENIA; RESPIRATORY TRACT INFECTIONS;

EID: 0037396165     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200304000-00015     Document Type: Article

References (16)

1. Coulthard S, Chase A, Pickard J, et al. Chromosomal breakage analysis in peripheral blood lymphocytes. Br J Haematol 1988;102:1162-4.
2. Davidson HR, Connor JM. Dyskeratosis congenita. J Med Genet 1988;25:843-6.
3. Ogden GR, Connor E, Chisholm DM. Dyskeratosis congenita: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol 1988;65:586-91.
4. Dokal I. Dyskeratosis congenita in all its form. Br J Haematol 2000;110:768-79.
5. Conner JM, Gatherer D, Gray FC, et al. Assignment of the gene for dyskeratosis congenita to Xq28. Hum Genet 1986;72:348-51.
6. Brown CL. Dyskeratosis congenita: report a case. Int J Paed Dent 2000;10:328-33.
7. Alter BP, Gardner FH, Hall RE. Treatment of dyskeratosis congenita with granulocyte colony-stimulating factor and erythropoietin. Br J Haematol 1997;97:309-11.
8. Dokal I. Dyskeratosis congenita: an inherited bone marrow failure syndrome. Br J Haematol 1996;92:775-9.
9. Russo CL, Glader BE, Israel RJ, et al. Treatment of neutropenia associated with dyskeratosis congenita with granulocyte macrophage-colony stimulating factor. Lancet 1990;336;751-2.
10. Langston AA, Sanders JE, Deeg HJ, et al. Allogeneic marrow transplantation for aplastic anemia associated with dyskeratosis congenita. Br J Haematol 1996;92:758-65.
11. Gillio AP, Gabrilove JL. Cytokine treatment of inherited bone marrow failure syndromes. Blood 1993;81:1669-74.
12. Oehler L, Reiter E, Friedl J, et al. Effective stimulation of neutropoiesis with rh G-CSF in dyskeratosis congenita: a case report. Ann Haematol 1994;69:325-7.
13. Pritchard SL, Junker AK. Positive response to granulocyte-colony-stimulating factor in dyskeratosis congenita before matched unrelated bone marrow transplantation. Am J Ped Hematol/Oncol 1994;66:86-7.
14. Bryan HG, Nixon RK. Dyskeratosis congenita and familial pancytopenia. JAMA 1965;192:203-6.
15. Dokal I. The inherited bone marrow failure syndromes: Fanconi anemia, dyskeratosis congenita and Diamond-Blackfan anemia. Reviews in Clinical and Experimental Hematology 2000;4:183-216.
16. Putterman C, Safadi R, Zlotogora J, et al. Treatment of the hematological manifestations of dyskeratosis congenita. Ann Haematol 1993;66:209-12.